Franziska Briest

The selective PI3Kα inhibitor BYL719 as a novel therapeutic option for neuroendocrine tumors: Results from multiple cell line models

Svenja Nölting, Jakob Rentsch, Helma Freitag et al. · PLoS ONE · 2017 · 33 citations · Full text

Inhibition of mTOR's Catalytic Site by PKI-587 Is a Promising Therapeutic Option for Gastroenteropancreatic Neuroendocrine Tumor Disease

Helma Freitag, Friederike Christen, Florentine Lewens et al. · Neuroendocrinology · 2016 · 32 citations · Full text

Genetic Characterization of Primary Mediastinal B-Cell Lymphoma: Pathogenesis and Patient Outcomes

Daniel Noerenberg, Franziska Briest, Cornelius Hennch et al. · Journal of Clinical Oncology · 2023 · 30 citations

Proteasome inhibitor bortezomib enhances the effect of standard chemotherapy in small cell lung cancer

Sanaz Taromi, Florentine Lewens, Ruža Arsenić et al. · Oncotarget · 2017 · 29 citations · Full text

Proteasome Inhibitors, Aggressive Cancer, Proteasome Inhibitor Bortezomib +19

FOXM1: A novel drug target in gastroenteropancreatic neuroendocrine tumors

Franziska Briest, Erika Gebel Berg, Irina Grass et al. · Oncotarget · 2015 · 27 citations · Full text